New Alzheimer's drug targets brain receptors to boost memory
Symptom relief
Recruiting now
This study tests a new drug called NSC001 in 90 people with mild to moderate Alzheimer's disease. The drug is designed to activate a specific receptor in the brain (M1 muscarinic) that may help with memory and thinking. The main goal is to check if the drug is safe and tolerable,…
Phase: PHASE1, PHASE2 • Sponsor: NSC-Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC